Detailansicht

Wissensnetz

Person

Martin Widschwendter

Gynäkologe

Name	Martin Widschwendter
Zeit	1993- (Wirkungsdaten)
Ort	Österreich Großbritannien
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. MD
Beruf	Gynäkologe (charakteristischer Beruf) Hochschullehrer
Beziehung	Universität Innsbruck University College London Onkologie (Thema)
Datensatztyp	Person
GND-Nummer	127600110X
Datensatz-ID	127600110X
Beteiligt an alle anzeigen Cervical cancer screening using DNA methylation triage in a real-world population DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies DNA methylation signatures to predict the cervicovaginal microbiome status A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases Women’s perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women’s Cancer: Points to Consider The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer Methylation patterns in serum DNA for early identification of disseminated breast cancer Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer development Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer Correlation of an epigenetic mitotic clock with cancer risk The multi-omic landscape of transcription factor inactivation in cancer Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer Stochastic epigenetic outliers can define field defects in cancer The lncRNA HOTAIR impacts on mesenchymal stem cells via triple helix formation The integrative epigenomic-transcriptomic landscape of ER positive breast cancer An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer The integrative epigenomic-transcriptomic landscape of ER positive breast cancer A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival Relationship between genome and epigenome - challenges and requirements for future research Relationship between genome and epigenome : challenges and requirements for future research CDK ‐mediated activation of the SCF FBXO 28 ubiquitin ligase promotes MYC ‐driven transcription and tumourigenesis and predicts poor survival in breast cancer A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer Epigenetic Downregulation of the Retinoic Acid Receptor-β2 Gene in Breast Cancer

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Martin Widschwendter

Cervical cancer screening using DNA methylation triage in a real-world population

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer

Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

Author Correction: Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women

Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock

Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies

DNA methylation signatures to predict the cervicovaginal microbiome status

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

Women’s perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey

Ethical, Legal, and Regulatory Issues for the Implementation of Omics-Based Risk Prediction of Women’s Cancer: Points to Consider

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

Methylation patterns in serum DNA for early identification of disseminated breast cancer

Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer development

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

Correlation of an epigenetic mitotic clock with cancer risk

The multi-omic landscape of transcription factor inactivation in cancer

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer

Stochastic epigenetic outliers can define field defects in cancer

The lncRNA HOTAIR impacts on mesenchymal stem cells via triple helix formation

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer

An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer

A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival

Relationship between genome and epigenome - challenges and requirements for future research

Relationship between genome and epigenome : challenges and requirements for future research

CDK ‐mediated activation of the SCF FBXO 28 ubiquitin ligase promotes MYC ‐driven transcription and tumourigenesis and predicts poor survival in breast cancer

A comparison of feature selection and classification methods in DNA methylation studies using the Illumina Infinium platform

Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

Epigenetic Downregulation of the Retinoic Acid Receptor-β2 Gene in Breast Cancer